Published in Healthcare Mergers, Acquisitions and Ventures Week, October 15th, 2005
Commenting on the year, R. Douglas Armstrong, PhD, CEO and Chairman of Aastrom, said, "We made significant strides in fiscal year 2005 and demonstrated our continued commitment to achieve progressive corporate milestones. Of particular note has been the movement of our TRCs into the clinic, and the interim results we have achieved in these patient treatments.
The support and interest that we are receiving from the medical field as well as regulatory agencies, should further our clinical progress as we expand our trials and move...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.